InsiderClue
← All stocks

Travere Therapeutics, Inc.

TVTX Mostly scheduled
CIK 0001438533 #1223 in the set updated 22 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$66.38M
$0.00 on a plan · $66.34M straight out of an exercise
Sold at will
$42.61K
1 of 41 sales
Net
−$66.38M
−$42.61K against sales at will

By person

16 insiders · 41 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Dube Eric M
CHIEF EXECUTIVE OFFICER
—
$25.39M (8) scheduled
−$25.39M
432,886
0.4592%
$28.12M
+19.6%
Heerma Peter
EVP, CHIEF COMMERCIAL OFFICER
—
$17.86M (7) scheduled
−$17.86M
117,066
0.1242%
$7.60M
+7.1%
ROTE WILLIAM E.
Chief Research Officer
—
$13.14M (6) scheduled
−$13.14M
98,197
0.1042%
$6.38M
+12.8%
Cline Christopher R.
CHIEF FINANCIAL OFFICER
—
$3.19M (5) scheduled
−$3.19M
87,508
0.0928%
$5.68M
+17.3%
Inrig Jula
EVP, Head of R&D & CMO
—
$2.79M (4) scheduled
−$2.79M
100,491
0.1066%
$6.53M
+62.2%
REED ELIZABETH E
Chief Legal Officer and GC
—
$2.34M (4) scheduled
−$2.34M
105,389
0.1118%
$6.85M
+31.2%
Meckler Jeffrey A
Director
—
$1.35M (4) scheduled
−$1.35M
91,500
0.0971%
$5.94M
+13.0%
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
—
$335.00K (3) scheduled
−$335.00K
42,353
0.0449%
$2.75M
−18.6%
LYONS GARY A
Director
—
—
—
61,500
0.0652%
$3.99M
+20.6%
Coughlin Timothy
Director
—
—
—
56,250
0.0597%
$3.65M
+14.8%
Baynes Roy D.
Director
—
—
—
41,500
0.0440%
$2.70M
+33.9%
Squarer Ron
Director
—
—
—
39,375
0.0418%
$2.56M
+36.4%
Orwin John A
Director
—
—
—
39,375
0.0418%
$2.56M
+36.4%
Poole Sandra
Director
—
—
—
34,000
0.0361%
$2.21M
+44.7%
Bruhn Suzanne Louise
Director
—
—
—
32,750
0.0347%
$2.13M
+47.2%
Williams Brinkley Ruth
Director
—
—
—
29,750
0.0316%
$1.93M
+54.5%

Individual transactions

41
Insider
Date
Role
Action
Shares
Price
Amount
Dube Eric M
17 Sep 2026
CHIEF EXECUTIVE OFFICER
Sold after exercise
6,802
$64.95
$441.80K
Dube Eric M
17 Sep 2026
CHIEF EXECUTIVE OFFICER
Sold after exercise
101,691
$64.59
$6.57M
Heerma Peter
17 Sep 2026
EVP, CHIEF COMMERCIAL OFFICER
Sold after exercise
8,282
$65.07
$538.92K
ROTE WILLIAM E.
16 Sep 2026
Chief Research Officer
Sold after exercise
47,746
$63.61
$3.04M
ROTE WILLIAM E.
16 Sep 2026
Chief Research Officer
Sold after exercise
65,104
$63.12
$4.11M
Dube Eric M
16 Sep 2026
CHIEF EXECUTIVE OFFICER
Sold after exercise
96,125
$63.64
$6.12M
Dube Eric M
16 Sep 2026
CHIEF EXECUTIVE OFFICER
Sold after exercise
99,716
$63.26
$6.31M
Heerma Peter
16 Sep 2026
EVP, CHIEF COMMERCIAL OFFICER
Sold after exercise
79,113
$63.65
$5.04M
Heerma Peter
16 Sep 2026
EVP, CHIEF COMMERCIAL OFFICER
Sold after exercise
93,604
$63.25
$5.92M
ROTE WILLIAM E.
15 Sep 2026
Chief Research Officer
Sold after exercise
270
$65.31
$17.63K
ROTE WILLIAM E.
15 Sep 2026
Chief Research Officer
Sold after exercise
3,000
$63.65
$190.95K
ROTE WILLIAM E.
15 Sep 2026
Chief Research Officer
Sold after exercise
29,021
$62.66
$1.82M
ROTE WILLIAM E.
15 Sep 2026
Chief Research Officer
Sold after exercise
63,907
$61.99
$3.96M
Calvin Sandra
15 Sep 2026
SVP, CHIEF ACCOUNTING OFFICER
Sold after exercise
300
$63.66
$19.10K
Calvin Sandra
15 Sep 2026
SVP, CHIEF ACCOUNTING OFFICER
Sold after exercise
800
$62.85
$50.28K
Calvin Sandra
15 Sep 2026
SVP, CHIEF ACCOUNTING OFFICER
Sold after exercise
4,275
$62.14
$265.63K
Cline Christopher R.
15 Sep 2026
CHIEF FINANCIAL OFFICER
Sold after exercise
400
$65.31
$26.12K
Cline Christopher R.
15 Sep 2026
CHIEF FINANCIAL OFFICER
Sold after exercise
1,900
$63.69
$121.00K
Cline Christopher R.
15 Sep 2026
CHIEF FINANCIAL OFFICER
Sold after exercise
20,735
$62.61
$1.30M
Cline Christopher R.
15 Sep 2026
CHIEF FINANCIAL OFFICER
Sold after exercise
27,473
$62.00
$1.70M
Dube Eric M
15 Sep 2026
CHIEF EXECUTIVE OFFICER
Sold after exercise
270
$65.31
$17.63K
Dube Eric M
15 Sep 2026
CHIEF EXECUTIVE OFFICER
Sold after exercise
3,102
$63.64
$197.42K
Dube Eric M
15 Sep 2026
CHIEF EXECUTIVE OFFICER
Sold after exercise
28,796
$62.66
$1.80M
Dube Eric M
15 Sep 2026
CHIEF EXECUTIVE OFFICER
Sold after exercise
63,498
$61.99
$3.94M
REED ELIZABETH E
15 Sep 2026
Chief Legal Officer and GC
Sold after exercise
300
$65.31
$19.59K
REED ELIZABETH E
15 Sep 2026
Chief Legal Officer and GC
Sold after exercise
1,400
$63.69
$89.17K
REED ELIZABETH E
15 Sep 2026
Chief Legal Officer and GC
Sold after exercise
13,874
$62.63
$868.96K
REED ELIZABETH E
15 Sep 2026
Chief Legal Officer and GC
Sold after exercise
21,926
$62.03
$1.36M
Inrig Jula
15 Sep 2026
EVP, Head of R&D & CMO
Sold after exercise
400
$65.31
$26.12K
Inrig Jula
15 Sep 2026
EVP, Head of R&D & CMO
Sold after exercise
1,600
$63.69
$101.90K
Inrig Jula
15 Sep 2026
EVP, Head of R&D & CMO
Sold after exercise
17,284
$62.62
$1.08M
Inrig Jula
15 Sep 2026
EVP, Head of R&D & CMO
Sold after exercise
25,390
$62.02
$1.57M
Heerma Peter
15 Sep 2026
EVP, CHIEF COMMERCIAL OFFICER
Sold after exercise
1,431
$65.31
$93.46K
Heerma Peter
15 Sep 2026
EVP, CHIEF COMMERCIAL OFFICER
Sold after exercise
1,400
$63.65
$89.11K
Heerma Peter
15 Sep 2026
EVP, CHIEF COMMERCIAL OFFICER
Sold after exercise
27,421
$62.59
$1.72M
Heerma Peter
15 Sep 2026
EVP, CHIEF COMMERCIAL OFFICER
Sold after exercise
71,938
$62.05
$4.46M
Meckler Jeffrey A
10 Sep 2026
Director
Sold after exercise
3,100
$68.09
$211.07K
Meckler Jeffrey A
10 Sep 2026
Director
Sold after exercise
14,000
$67.46
$944.49K
Meckler Jeffrey A
10 Sep 2026
Director
Sold after exercise
1,200
$66.15
$79.38K
Meckler Jeffrey A
10 Sep 2026
Director
Sold after exercise
1,700
$65.39
$111.17K
Cline Christopher R.
2 Sep 2026
CHIEF FINANCIAL OFFICER
Sell
642
$66.37
$42.61K

What was left out

Form 4 filings counted 9
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 40
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 964,959
History held since 2 Sep 2016